VERAXA appoints Carl von Halem as interim chief financial officer

The Nasdaq-listed biotech said he succeeds Torsten Bürgermeister as it nears a permanent finance leadership appointment to support its next phase of expansion and operational growth.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.